13 D Management LLC Ironwood Pharmaceuticals Inc Transaction History

13 D Management LLC

$159 Million
Q1 2024

A detailed history of 13 D Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, 13 D Management LLC holds 419,284 shares of IRWD stock, worth $2.61 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares

419,284

Previous 367,649 14.04%

Holding current value

$2.61 Million

Previous $4.21 Million 13.17%

% of portfolio

2.3%

Previous 2.61%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $429,603 - $797,760	51,635 Added 14.04%	419,284 $3.65 Million
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $2.93 Million - $3.84 Million	333,348 Added 971.83%	367,649 $4.21 Million
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $3.93 Million - $5.41 Million	-476,806 Reduced 93.29%	34,301 $330,000
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $226,795 - $260,478	-22,455 Reduced 4.21%	511,107 $5.44 Million
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $662,003 - $831,181	-66,869 Reduced 11.14%	533,562 $6.61 Million

Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $412,474 - $474,812	37,328 Added 6.63%	600,431 $6.92 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $527,847 - $640,780	-49,750 Reduced 8.12%	563,103 $7.08 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $408,357 - $524,547	-37,602 Reduced 5.78%	612,853 $7.15 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $76,829 - $99,137	-7,562 Reduced 1.15%	650,455 $8.37 Million
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $2.6 Million - $3.41 Million	287,582 Added 77.63%	658,017 $7.36 Million
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $596,277 - $803,821	-65,887 Reduced 15.1%	370,435 $4.22 Million
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $51,045 - $60,981	5,678 Added 1.32%	436,322 $3.93 Million
Q2 2020 Aug 14, 2020	SELL	$9.14 - $11.97 $158,341 - $207,368	-17,324 Reduced 3.87%	430,644 $4.44 Million
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $233,504 - $381,282	27,215 Added 6.47%	447,968 $4.52 Million
Q4 2019 Feb 13, 2020	SELL	$8.22 - $14.0 $757,571 - $1.29 Million	-92,162 Reduced 17.97%	420,753 $5.6 Million
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $200,877 - $256,299	23,385 Added 4.78%	512,915 $4.4 Million
Q2 2019 Aug 14, 2019	BUY	$9.8 - $12.89 $4.8 Million - $6.31 Million	489,530 New	489,530 $5.36 Million

Others Institutions Holding IRWD

# of Institutions

296

Shares Held

170M

Call Options Held

27.1M

Put Options Held

2.28M

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $953M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 13 D Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 13 D Management LLC with notifications on news.

Account

13 D Management LLC Ironwood Pharmaceuticals Inc Transaction History